Who has invested in RenBio?

Ruentex Group, Wellcome Trust, Bill & Melinda Gates Foundation, DARPA are named among the investors backing RenBio.

RenBio Funding: $49M Raised, Series A (2021)

RenBio funding overview

RenBio is based in Long Island City, New York. RenBio has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2021. The round record for RenBio runs through 2021; nothing later has been disclosed. Investors on record include Ruentex Group, Wellcome Trust, Bill & Melinda Gates Foundation, DARPA. 4 distinct backers are named across the disclosed rounds.

RenBio at a glance

Total raised: $49M
Latest round: Series A
Latest round date: July 2021
Headquarters: Long Island City, New York
Notable investors: Ruentex Group, Wellcome Trust, Bill & Melinda Gates Foundation, DARPA

Frequently asked about RenBio funding

How much has RenBio raised?: RenBio has raised $49M in total disclosed funding across the rounds on record.
Who has invested in RenBio?: Ruentex Group, Wellcome Trust, Bill & Melinda Gates Foundation, DARPA are named among the investors backing RenBio.
What was the latest RenBio funding round?: The most recent disclosed round is a Series A, announced in July 2021.
Where is RenBio based?: RenBio is based in Long Island City, New York.
When did RenBio last raise?: The last disclosed RenBio round closed in July 2021 at Series A.

Round data for RenBio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Long Island City and backer lists below.

RenBio Funding: $49M Raised, Series A (2021)

RenBio funding overview

RenBio at a glance

Frequently asked about RenBio funding

Companies related to RenBio (32)

Browse related funding lists (4)